The IPO will consist of a primary issue and offer for sale from its promoter Satish Mehta and existing investor Bain Capital which acquired...

The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of 400 million doses of its potential C...

Spain, which is the worst affected country after Italy, reportedly found out that rapid coronavirus test kits purchased from a Chinese firm...

Drug firm Jubilant Life Sciences' subsidiary Drug Discovery and Development Solutions Ltd (DDDSL) Singapore has entered into an agreement t...

The two funds together hold a 23% stake and the remainder is with the Daftary family.

Here is a list of top stocks that are likely to be in focus in today's trading session.

The vaccine to prevent infant deaths and hospitalisations due to rotavirus diarrhoea was launched by Prime Minister Narendra Modi in March ...

CCI has approved medical equipment firm Wipro GE Healthcare's proposed deal to acquire GE group's assets related to bio-technology and life...

According to Nasdaq, the stock price of ISIS Pharmaceuticals crossed above its 200-day moving average for the first time since early spring.

ISIS Pharmaceuticals, a $4.3 billion biotech firm surged 10% today, and it's up 43% in the last three months.

Private equity firm TPG has picked a minority stake in children’s apparel and accessories retailer Lilliput Kidswear for Rs 120 crore, a to...

Many firms -- Pfizer, Merck, Wyeth, Eli Lilly and Abbott Laboratories, which are under investigation by SEC have significant presence in In...

US-based biotechnology firm Novavax has formed a joint venture with Cadila Pharmaceuticals for developing and commercialising virus-like pa...

The government is likely to announce a National Offset Policy, under which foreign vendors would have to procure at least 40% of the contra...

Venture capitalists pumped a record $9.1 billion into privately-held US biotechnology and medical device companies last year, in hopes of m...

Fidelity Investments is in advanced talks to buy 12-14% stake in the Bangalore-based biotech firm Avesthagen for $10-12 million.

Trans-India Acquisition Corp, a US-based "blank check" investment firm interested in acquiring pharma companies in India, is tapping the Na...